AUSTRALIAN BEAUTY-TECH BUYING INTELLIGENCE
← The journal

CLINIC / BUYING NOTES · RESEARCH CHECKED 15 NOV 2026

Secret RF versus Potenza: what a clinic should compare before choosing

Illustrative beauty technology editorial scene

AI-generated editorial illustration; not a photograph of a named device.

Secret RF and Potenza both appear in RF microneedling equipment discussions. A useful comparison needs to go beyond asking which name is more popular or which brochure lists more options.

The clinic is buying an exact configuration, support arrangement and set of capabilities. It also needs evidence that is relevant to the services it plans to provide and a clear view of the clinical and operational responsibilities involved.

This is a source-based procurement comparison. It does not establish a clinical winner, verify either device's current Australian labelled indications, or provide treatment settings.

Start with the source date

Our Secret RF technical detail partly comes from a Cutera brochure dated February 2022. That is useful published information, but it is not a substitute for a current Australian package specification.

Potenza detail comes from the Jeisys Australian product page checked on 15 November 2026. That page also notes that features and consumables can vary with version and region.

Put those differences in source currency beside the specifications. Do not quietly present an older global brochure and a current regional page as equally complete audits of what suppliers will deliver today.

Compare the stated technical differences

The Secret RF brochure describes bipolar RF at 2 MHz, with a stated depth range of 0.5–3.5 mm in 0.1 mm increments. It lists 25-pin non-insulated and semi-insulated options and a 64-pin semi-insulated option.

The Potenza Australian page describes monopolar and bipolar options, 1 MHz and 2 MHz modes, and invasive and non-invasive options. It states a 0.5–4.0 mm range in 0.25 mm increments, with a different range for CP tips.

These are manufacturer specifications. A broader mode range, deeper maximum or finer increment does not establish better outcomes. The important question is which capabilities are relevant, supported and included in the exact package your clinic would buy.

Ask suppliers to confirm the configuration and applicable instructions in writing. Do not translate these published ranges into treatment advice.

Match the evidence to the decision

Evidence about RF microneedling as a technology provides context. Exact-device research can answer more specific questions, provided the tested model, protocol and intended use match the buying decision.

For each paper or report, record the study design, actual participant count, comparison, outcomes, follow-up and funding. Ask whether a study compares devices, adds another treatment to the same device, or observes changes without a control group.

A registered study protocol describes a plan. It should not be presented as if it contains completed efficacy results. Missing or unverified results in a bounded review also do not establish that no research exists elsewhere.

This review did not establish head-to-head clinical superiority of Secret RF over Potenza or the reverse. A supplier should be able to identify the research relevant to its current model and your proposed service, with limitations intact.

Include the safety context accurately

In October 2025, the US FDA warned that serious complications had been reported with certain uses of RF microneedling. Its listed examples include burns, scarring, fat loss and nerve damage. The communication is relevant safety context and does not provide a comparative rate for these two products.

It is also not an Australian ban or an exact Australian regulatory determination. Keep overseas safety information, Australian supply status and device-specific instructions as separate checks.

Ask how the supplier supports appropriate training, ongoing competence, maintenance and escalation when a problem occurs. This article does not address patient selection or treatment parameters.

Compare the consumable commitment

For the tips and handpieces in your intended workflow, ask for the price, permitted use, pack quantity, minimum orders, shelf life where relevant, availability and any storage requirements.

Confirm the exact instructions governing use. Do not assume that a lower stated per-tip price means a lower permitted per-treatment cost. The number of components used, replacement requirements and wastage assumptions must match the actual workflow.

Then put verified per-treatment costs into the same ownership model for each quote. Keep costs marked unknown until the written terms support an entry.

Compare support as an operating requirement

Ask who services the equipment locally, what the warranty excludes, whether travel or call-out fees apply, and how faults are handled. Establish what happens when the device cannot be used.

A supplier response-time promise needs clear terms. Does it cover an initial response, an onsite visit, a repair or access to loan equipment? Those are different commitments.

Training should be equally specific: attendees, format, prerequisites, included refreshers and charges for new team members. Record the assumptions that would remain the clinic's responsibility after purchase.

Use a written comparison sheet

Your decision record should contain the current model and package, relevant evidence, Australian supply and intended-purpose documents, consumable costs, training and local support. Keep clinical suitability and commercial modelling as distinct parts of that record.

The TGA's advertising guidance requires supported claims and consistency with the relevant Australian entry or applicable labelling. Overseas marketing language alone should not become a verified Australian indication in your comparison or future promotion.

If a supplier's answer changes a material field, update the comparison rather than preserving a convenient earlier conclusion.

The useful conclusion

The procurement question is which exact offer meets your clinic's documented requirements, with acceptable evidence, support and ownership costs. It is a stronger decision when the remaining uncertainties are visible.

Use the three-year ownership guide to model the written offers. Keep the specification sheet beside the calculator so a lower cost does not silently stand in for clinical equivalence.

Sources and scope

Research checked 15 November 2026. No hands-on testing, supplier quote, Australian exact-model ARTG verification or comparative treatment recommendation is claimed.

This procurement article contains no active affiliate links or supplier endorsements.